International Journal of Neuropsychopharmacology (IJNP)

Home
CINP Journal

CINP is pleased that its relationship with Oxford University Press (OUP), as the publisher of our official Journal, the International Journal of Neuropsychopharmacology (IJNP), has progressed very nicely since its inception in 2015. The move to OUP was associated with the IJNP becoming a fully open-access journal. This has expedited articles being published more rapidly but has also broadened its availability to investigators world-wide and increased those with access to it. Evidence for this is that the total number of downloads of our articles has increased almost fourfold and now averages about 52,000/month, according to Editor-in-Chief Alan Frazer (photo).

If you would like to submit an article, please read the author guidelines before uploading. A benefit to being a CINP member with respect to the open access fee is provided, being $1500 per article for members but $2200/article for non-members.

Author Guidelines

Submit Your article here

The central focus of the International Journal of Neuropsychopharmacology (IJNP) is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment.

IJNP has an Impact Factor of 4.207 and a 5-year Impact Factor of 4.390 according to the most recent Journal Citation Reports® (Thomson Reuters). This places the journal 42 out of 261 in the category of Pharmacology & Pharmacy. The Impact Factor is the average number of times articles from the journal published in the past two years have been cited in the JCR year. The Impact Factor is calculated by dividing the number of citations in the JCR year by the total number of articles published in the two previous years. The five-year Impact Factor is calculated in the same way as the standard Impact Factor, except the standard two-year window for inclusion of articles is extended to five years.

Current statistics about the Journal are shown in the infographic and illustrate the rapid speed of online publication from final acceptance of the article.

Professor Siegfried Kasper, current CINP president, stated, “IJNP has been an important part of the life of the CINP and a venue for the publication of outstanding and impactful science. Under the leadership of our editor-in-chief, Anthony Grace, our outstanding collaboration with Oxford University Press is helping us to increase the visibility of papers appearing in IJNP. It is also making IJNP more user-friendly for both contributing authors and readers.”

IJNP’s focus is on research which advances the understanding of neuropsychopharmacological agents and more novel treatment modalities such as stimulation approaches, including their clinical applications, or which provides insights into the biological basis of neuropsychiatric disorders and thereby advances their treatment.

Past Issues

You can find all IJNP issues from the past four years below. Click here to view all.

IJNP Team

To ensure high quality standards of the published articles, the IJNP Team consists of worldwide known experts in the field of neuropsychopharmachology who support the journal with their expertise in certain fields. The Editorial Board gives support in these activities and constantly reviews the submitted articles.

Contact us